Iontophoresis-Integrated Smart Microneedle Delivery Platform for Efficient Transdermal Delivery and On-Demand Insulin Release DOI

Mingwei Peng,

Ziwen Heng,

Dewei Ma

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(51), С. 70378 - 70391

Опубликована: Дек. 12, 2024

Transdermal insulin delivery in a painless, convenient, and on-demand way remains long-standing challenge. A variety of smart microneedles (MNs) fabricated by glucose-responsive phenylboronic acid hydrogels have been previously developed to provide painless autonomous release response glucose level change. However, like the majority MNs, their transdermal efficiency was still relatively low compared that with subcutaneous injection. Herein, we report an iontophoresis (ITP)-integrated MNs platform enhanced depth. Carbon nanotubes (CNTs) were induced boronate-containing hydrogel develop semi-interpenetrating network stiffness conductivity. Remarkably, ITP not only facilitated efficient deeper via electroosmosis electrophoresis but also well-maintained responsiveness. This ITP-combined platform, which could safe way, is promising achieve persistent glycemic control. Furthermore, payloads wide size range achieved this thus shed light on development deep skin penetration minimally invasive way.

Язык: Английский

Transethosomes: A Comprehensive Review of Ultra-Deformable Vesicular Systems for Enhanced Transdermal Drug Delivery DOI Creative Commons

Raagul Seenivasan,

Praveen Halagali, Devika Nayak

и другие.

AAPS PharmSciTech, Год журнала: 2025, Номер 26(1)

Опубликована: Янв. 17, 2025

Язык: Английский

Процитировано

2

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics DOI

Xiaochun Bian,

Liping Zhou,

Zhiwei Luo

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Янв. 21, 2025

Nucleic acid therapeutics represent a highly promising treatment approach in modern medicine, treating diseases at the genetic level. However, these face numerous challenges practical applications, particularly regarding their stability, effectiveness, cellular uptake efficiency, and limitations delivering them specifically to target tissues. To overcome obstacles, researchers have developed various innovative delivery systems, including viral vectors, lipid nanoparticles, polymer inorganic protein carriers, exosomes, antibody oligonucleotide conjugates, DNA nanostructure-based systems. These systems enhance therapeutic efficacy of nucleic drugs by improving targeting specificity, half-life vivo. In this review, we systematically discuss different types drugs, analyze major barriers encountered delivery, summarize current research progress emerging We also highlight latest advancements application for diseases, infectious cancer, brain wound healing. This review aims provide comprehensive overview drug systems' status future directions integrating nanotechnology, biomaterials science, gene editing technologies, emphasizing transformative potential precision medicine.

Язык: Английский

Процитировано

2

Formation of drug–drug salt crystals and co-amorphous forms of levofloxacin and 4-aminosalicylic acid for pulmonary applications DOI Creative Commons
Hiroshi Ueda,

Jun Yee Tse,

Tetsuya Miyano

и другие.

RSC Pharmaceutics, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Simultaneous delivery with improvement of inhalation properties levofloxacin and 4-aminosalicylic acid through the formation drug–drug salts.

Язык: Английский

Процитировано

1

Nanoformulation-assisted microneedle transdermal drug delivery system: An innovative platform enhancing rheumatoid arthritis treatment DOI Open Access

Yao Wendong,

Yan Xingxing,

Xie Xianze

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 178, С. 117219 - 117219

Опубликована: Июль 30, 2024

A transdermal delivery system offers high bioavailability and favorable patient adherence, constituting an optimal approach for localized administration in rheumatoid arthritis (RA) treatment. However, the stratum corneum (SC) impedes efficiency of conventional drug systems. Microneedles (MNs) can temporarily create micropores within SC, enabling distribution via bypassing this barrier enhancing effectiveness. Notably, MNs provide a painless method through skin may directly modulate inflammation immune cells by delivering drugs lymphatic during administration. MN is not suitable with low water solubility stability. Additionally, major concerns exist regarding safety using highly cytotoxic drugs, given that it could result local concentration at site. While exhibit some degree targeted to inflammatory environment, their targeting remains suboptimal. Nanoformulations have potential significantly address limitations RA treatment improving targeting, solubility, stability, biocompatibility. Therefore, review provides concise overview advantages, disadvantages, mechanisms different types It specifically focuses on application advantages combining nanoformulation summarizes current trends development nanoformulations combined field treatment, offering theoretical support future advancements clinical applications.

Язык: Английский

Процитировано

5

Dissolving microneedles: A transdermal drug delivery system for the treatment of rheumatoid arthritis DOI

X. Wang,

Jiang Yue, Sun‐Wei Guo

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер unknown, С. 125206 - 125206

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Harnessing Ultrasonic Technologies to Treat Staphylococcus Aureus Skin Infections DOI Creative Commons
John Hulme

Molecules, Год журнала: 2025, Номер 30(3), С. 512 - 512

Опубликована: Янв. 23, 2025

The rise of antibiotic-resistant Staphylococcus aureus strains, particularly MRSA, complicates the management skin and soft tissue infections. This review highlights ultrasonic methodologies as adjunctive therapies to combat S. aureus-driven infections prevent progression biofilm formation chronic wounds. Low- high-frequency ultrasound (LFU HFU) demonstrate potential in disrupting biofilms, enhancing drug delivery, promoting repair through cavitation microbubble activity. These approaches integrate frequencies with microbubbles therapeutics, such antibiotics affimers, minimize resistance improve healing. Tailoring bioeffects on structures localized delivery technologies, including microneedle patches piezoelectric systems, presents promising solutions for early intervention structure (SSSIs).

Язык: Английский

Процитировано

0

Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models DOI Creative Commons
Dewald Steyn, Anja Haasbroek‐Pheiffer, Wihan Pheiffer

и другие.

Pharmaceuticals, Год журнала: 2025, Номер 18(2), С. 195 - 195

Опубликована: Янв. 31, 2025

Drugs administered by means of extravascular routes drug administration must be absorbed into the systemic circulation, which involves movement molecules across biological barriers such as epithelial cells that cover mucosal surfaces or stratum corneum covers skin. Some drugs exhibit poor permeation membranes may experience excessive degradation during first-pass metabolism, tends to limit their bioavailability. Various strategies have been used improve Absorption enhancement include co-administration chemical enhancers, enzymes, and/or efflux transporter inhibitors, changes, and specialized dosage form designs. Models with physiological relevance are needed evaluate efficacy absorption techniques. in vitro cell culture models ex vivo tissue explored quantify effectiveness strategies. This review deliberates on use for evaluation selected including nasal, oromucosal, pulmonary, oral, rectal, transdermal administration.

Язык: Английский

Процитировано

0

Skin-penetrating peptides (SKPs): Enhancing skin permeation for transdermal delivery of pharmaceuticals and cosmetic compounds DOI
Aliyu Muhammad, Ahmad Filza Ismail, Pei Pei Chong

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер unknown, С. 125339 - 125339

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Electromagnetic Fields, Electrical Stimulation, and Vacuum Simultaneously Applied for Major Burn Scars DOI Creative Commons

Salvatore Marafioti,

Sheila Veronese,

Claudio Pecorella

и другие.

Bioengineering, Год журнала: 2025, Номер 12(2), С. 179 - 179

Опубликована: Фев. 13, 2025

Regeneration in the case of major burn subjects must involve tissue and structural regeneration, but also functional as scars derived from burns often compromise motility. Electromagnetic fields electrical stimulation may be a possible treatment for these cases, considering they cause thermal effect magneto-mechanical transduction first selective second. A majorly burned woman with severe motor deficits, treated electromagnetic vacuum, associated personalized nutritional program, was described. The latter necessary to favor weight loss preservation weakened structure. Ultrasonography, Doppler ultrasound, body composition were measured. Moreover, postural evaluation performed. Immediately after treatment, restructuring all seen. After 6 months, regeneration evident, neo-angiogenesis. From point view, her motility improved, she stopped using walker. combined therapy allows obtain unthinkable results short time. For this reason, it could become elective scars.

Язык: Английский

Процитировано

0

Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas DOI Creative Commons
Lin Ren, Xiaowen Xu, Xianbin Liu

и другие.

Drug Design Development and Therapy, Год журнала: 2025, Номер Volume 19, С. 1163 - 1183

Опубликована: Фев. 1, 2025

Infantile hemangiomas (IHs) are a kind of skin soft tissue benign tumors in infants, with high incidence rate and significant harm. Rapid early proliferation can cause severe cosmetic deformities organ development disorders. Propranolol Hydrochloride (PRH), non-selective adrenergic β-receptor blocker, has become the first-line treatment for IHs due to its good efficacy safety compared other drugs. To further improve bioavailability PRH, deliver it more safely effectively lesion site, enhance patient compliance, researchers continually developing new PRH formulations IHs. This article briefly introduced pathogenesis therapeutic mechanism PRH. It also provided detailed overview various developed over past 12 years IHs, including improved oral formulations, topical creams, gels, liposomes/nanoparticles, transdermal patches, microneedles, targeted injectable formulations. summarized prospects technical challenges these aims provide comprehensive review recent advances propranolol technologies treating offering reference research application. At same time, is hoped that be efficiently used clinical practice future.

Язык: Английский

Процитировано

0